Sharing our research at the 2024 TSRC

Dr. Vergara gave a compelling presentation entitled "Menthol, Blueberry, and Watermelon NJOY ACE Promotes Significantly Greater Complete Switching Compared to Tobacco-flavored NJOY ACE". During her presentation, Dr. Vergara shared a summary of evidence submitted to FDA that led to FDA’s determination of the NJOY Menthol being “appropriate for the protection of public health.” She also presented findings from the NJOY ACE 2.0 Bluetooth enabled PMTA submitted to FDA earlier this year.
Dr. Vergara also participated on the panel, “Weight of the Evidence: Assessing the Benefits of Smokefree Alternatives to Adults Who Smoke and the Risk of Underage Initiation.” Her presentation featured research demonstrating the benefit to the population of current smokers who completely switched to NJOY ACE.
Dr. Hong presented his poster entitled "Characterization of Nicotine Pharmacokinetics and Subjective Effects During Use of Heated Tobacco Products in Adults Who Smoke".
He shared how the data suggests the prototype Ploom® System can potentially provide U.S. adults who smoke with an option to advance tobacco harm reduction.